Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Bristol Myers Squibb
Bristol Myers Squibb
Positive topline data for Bolt’s BDC-1001 in HER2 solid tumours
Clinical Trials Arena
Fri, 03/31/23 - 10:22 am
Bolt Biotherapeutics
BDC-1001
solid tumors
Roche
Bristol Myers Squibb
Pfizer, BMS' Eliquis tops list of drugs destined for Medicare price negotiations in 2026
Fierce Pharma
Thu, 03/30/23 - 10:59 am
Pfizer
Bristol Myers Squibb
Eliquis
drug pricing
Inflation Reduction Act
CMS
Could This Drug Candidate Be a Winner for These 2 Big Pharma Stocks?
Motley Fool
Tue, 03/28/23 - 10:46 pm
clinical trials
Bristol Myers Squibb
JNJ
milvexian
stroke
BMS re-ups 'highly productive' legacy neurodegeneration partnership with Evotec for $50M upfront
Fierce Biotech
Tue, 03/28/23 - 10:44 pm
Bristol Myers Squibb
Celgene
Evotec
neurodegenerative disease
Top 10 pharma R&D budgets in 2022
Fierce Biotech
Mon, 03/27/23 - 10:21 pm
R&D
Roche
JNJ
Merck
Pfizer
Novartis
AstraZeneca
Bristol Myers Squibb
Eli Lilly
Sanofi
AbbVie
Takeda, chasing Bristol Myers, unveils awaited TYK2 drug data
BioPharma Dive
Sun, 03/19/23 - 01:46 pm
Takeda
Bristol Myers Squibb
clinical trials
TAK-279
plaque psoriasis
Most-clicked pharma news for week ending March 18 2023: Medtronic offers early retirement package, Novartis to sell ophthalmological assets, and Pfizer tops list of drugs with price increases
CP WIre
Sat, 03/18/23 - 03:37 pm
Medtronic
Medtech
inflation
drug pricing
Pfizer
Novartis
Merck
Bristol Myers Squibb
Keytruda
Opdivo
Yervoy
lung cancer
Xiidra
JNJ
executive compensation
Most-clicked pharma news for week ending March 18 2023: Medtronic offers early retirement package, Novartis to sell ophthalmological assets, and Pfizer tops list of drugs with price increases
Sat, 03/18/23 - 03:35 pm
Medtronic
Medtech
inflation
drug pricing
Pfizer
Novartis
Merck
Bristol Myers Squibb
Keytruda
Opdivo
Yervoy
lung cancer
Xiidra
JNJ
executive compensation
Bristol Myers meets some diversity goals early, while missing others
Endpoints
Wed, 03/15/23 - 09:28 pm
Bristol Myers Squibb
diversity
clinical trials
clinical trial diversity
Bristol Myers blasts off with SpaceX to study biomanufacturing in space
Endpoints
Wed, 03/15/23 - 09:18 pm
Bristol Myers Squibb
SpaceX
Exscientia builds cancer pipeline with two BMS drugs
Pharmaphorum
Wed, 03/15/23 - 09:57 am
Exscientia
Bristol Myers Squibb
oncology
EXS73565
EXS74539
In PD-1 rivalry, Merck's Keytruda catches up with Opdivo in rare lung cancer type
Fierce Pharma
Fri, 03/10/23 - 11:20 am
Merck
Keytruda
Opdivo
Bristol Myers Squibb
pleural mseothelioma
mesothelioma
clinical trials
Bristol Myers axes German launch of new cancer drug, citing pricing hurdles
Endpoints
Tue, 03/7/23 - 10:37 pm
Bristol Myers Squibb
Germany
Opdivo
Opdualag
Bristol Myers dodges one $6.4B Celgene buyout CVR suit, but the battle is far from over
Fierce Pharma
Thu, 03/2/23 - 10:45 pm
Bristol Myers Squibb
Breyanzi
Celgene
legal
M&A
CVRs
Bristol Myers, J&J plan tests of new blood thinner in nearly 50,000 patients
BioPharma Dive
Thu, 03/2/23 - 10:41 pm
Bristol Myers Squibb
JNJ
clinical trials
Librexia
bloodthinners
New Report Reveals Pharmaceutical Industry Social Media Pioneers
LBB Online
Fri, 02/24/23 - 08:52 am
Ogilvy Health
social media
Bristol Myers Squibb
Boehringer Ingelheim
Roche
Bristol Myers expands footprint in India with drug development and IT center
Endpoints
Thu, 02/23/23 - 04:28 pm
Bristol Myers Squibb
India
drug development
IT
Big pharma’s looming threat: a patent cliff of ‘tectonic magnitude’
BioPharma Dive
Tue, 02/21/23 - 11:05 am
Big Pharma
patents
patent cliff
biosimilars
AbbVie
Humira
Merck
Keytruda
Bristol Myers Squibb
Opdivo
Bristol Myers details landmark Abecma multiple myeloma data that ASH turned down
Fierce Pharma
Sun, 02/12/23 - 07:46 pm
Bristol Myers Squibb
Abecma
CAR-T
Multiple Myeloma
BMS returns $475M IL-12 oncology asset to Dragonfly’s pond
Fierce Biotech
Mon, 02/6/23 - 06:12 pm
Dragonfly Therapeutics
Bristol Myers Squibb
oncology
DF6002
solid tumors
Pages
« first
‹ previous
…
3
4
5
6
7
8
9
10
11
…
next ›
last »